- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Carboplatin/Paclitaxel
Total 5603 results
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
OSI PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, United Kingdom
-
Shandong Cancer Hospital and InstituteRecruitingUnresectable Stage III NSCLCChina
-
Konkuk University Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Asan Medical Center; Seoul... and other collaboratorsCompletedOvarian CarcinomaKorea, Republic of
-
AmgenTakedaTerminatedNon-Small Cell Lung Cancer
-
Mateon TherapeuticsTerminatedAnaplastic Thyroid CancerUnited States, India, Belarus, Bulgaria, Egypt, Israel, Italy, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
Northwestern UniversityBristol-Myers Squibb; Lantheus Medical Imaging; CarTheraRecruitingGlioblastoma | Glioblastoma Multiforme | Gliosarcoma | GBM | Recurrent Glioblastoma | Glioblastoma, IDH-wildtypeUnited States
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UKRecruiting
-
Replimune Inc.Bristol-Myers SquibbWithdrawnSquamous Cell Carcinoma of Head and Neck | Recurrent Head and Neck Squamous Cell Carcinoma | Locally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, United Kingdom, Czechia, France, Germany, Greece, Poland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Duke UniversityCompleted
-
PfizerTerminatedOvarian CancerUnited States, Canada, United Kingdom, Korea, Republic of, Netherlands, Hong Kong, Singapore, Ireland, Estonia, Japan, Taiwan, Italy, Turkey, Slovakia, Germany, Poland, Switzerland, Croatia, Hungary, Bulgaria, Latvia, Mexico, Romania, Russian Federation and more
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Terminated
-
AbbVieCompleted
-
SanofiGynecologic Oncology GroupCompleted
-
Tesaro, Inc.Active, not recruitingNeoplasms | Solid Tumor | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownNon-small Cell Lung Cancer
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbActive, not recruitingPrimary Peritoneal Cancer | Fallopian Tube | High Grade Serous OvarianUnited States
-
Oslo University HospitalBristol-Myers SquibbActive, not recruitingEsophageal CancerNorway
-
University of California, San FranciscoCompletedOvarian Cancer | Lung Cancer | NeurotoxicityUnited States
-
The First Affiliated Hospital of Guangzhou Medical...RecruitingNeoplasms | Antineoplastic Agents | Carcinoma, SquamousChina
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Antisoma ResearchCompleted
-
West Japan Thoracic Oncology GroupCompleted
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
Samsung Medical CenterRecruitingNon-small Cell Lung CancerKorea, Republic of
-
CelgeneCompletedNon-Small Cell Lung CarcinomaUnited States, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEndometrial Carcinoma | Recurrent or Metastatic | TP53 MutationChina
-
iTeos TherapeuticsMerck Sharp & Dohme LLCActive, not recruitingSolid Tumor, AdultSpain, United States, France, Korea, Republic of, Belgium, United Kingdom
-
NCIC Clinical Trials GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; Grupo Español...CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Sichuan UniversityRecruiting
-
Guangdong Provincial People's HospitalRecruitingNon Small Cell Lung Cancer | EGFR Gene MutationChina
-
Guangdong Provincial People's HospitalRecruitingNon-small Cell Lung Cancer | EGFR Activating MutationChina
-
CelgeneCompletedAdenocarcinoma | Carcinoma | Non-Small Cell Lung Cancer | Carcinoma, Large Cell | Squamous Cell Carcinoma | Lung NeoplasmUnited States
-
Medical Research CouncilCancer Research UKUnknown
-
University of WashingtonNational Cancer Institute (NCI); United States Department of DefenseRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Yale UniversityTerminatedCarcinoma, Non-small Cell LungUnited States
-
AbbVie (prior sponsor, Abbott)Completed
-
Merck Sharp & Dohme LLCTerminatedStage IIIB or IV Non-Small Cell Lung Cancer
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedChemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerLung Cancer | Drug/Agent Toxicity by Tissue/OrganUnited States
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingHuman Papilloma Virus Infection | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage IVA Squamous Cell Carcinoma of the Oropharynx | Stage IVB Squamous Cell Carcinoma of the OropharynxUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingEsophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
University of Texas Southwestern Medical CenterCompletedHead and Neck Cancer | Carcinoma, Squamous Cell | Neoplasms, Oral | Neoplasms, PharyngealUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
Human Genome Sciences Inc., a GSK CompanySuspended
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung CancerUnited States
-
Shanghai Chest HospitalNot yet recruitingEsophageal Squamous Cell CarcinomaChina